NCT01906762

Brief Summary

Kidney stone is one of the most common diseases in every human society and also Iran. What is normally used to treat renal colic pain is Intravenous Opioid with a variety of side effects including hypotension, respiratory depression and apnea, nausea and vomiting. Regarding less complications of Intravenous Acetaminophen, we aimed to compare it with Intravenous Morphine in management of renal colic pain.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Jul 2012

Shorter than P25 for phase_2

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2012

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 20, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 24, 2013

Completed
Last Updated

July 24, 2013

Status Verified

July 1, 2013

Enrollment Period

7 months

First QC Date

July 20, 2013

Last Update Submit

July 20, 2013

Conditions

Keywords

Morphine, Acetaminophen, Renal colic, Emergency treatment

Outcome Measures

Primary Outcomes (1)

  • Pain

    patient's pain was assessed by using a Visual Analog Scale Ruler, that rates the amount of pain from 0 to 10 based on patient's confession. Patient's pain was checked out twice: exactly before receiving the pain reliever, and 30 minutes later.

    30 Minutes

Study Arms (2)

Acetaminophen

EXPERIMENTAL

Specified dosage for Acetaminophen was 15 mg/kg. so based on the patient's weight(averagely 70 kg), about 1gr Acetaminophen (one complete Apotel Ampule) was used.

Drug: Acetaminophen

Morphine

EXPERIMENTAL

Specified dosage for Morphine was 0.1 mg/kg. so based on the patient's weight(averagely 70 kg), about 7 mg Morphine was used.

Drug: Morphine

Interventions

This protocol prepared by a nurse and labeled as Drug A. Since the rapid injection of Acetaminophen can result in hypotension, therefore based on the Apotel Injection Instruction, it must be infused slowly within 15 minutes.

Also known as: Apotel
Acetaminophen

This protocol was prepared by a nurse and labeled as Drug B. Since the rapid injection of Morphine can result in histamine release, therefore it must be infused slowly within 15 minutes. The nurse, who was in charge of infusing pain reliever, was unaware of the type of injected drug.

Also known as: Morphine Sulfate
Morphine

Eligibility Criteria

Age15 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • aged 15 to 80 years
  • weight of 60 to 80 kilograms
  • known case of renal colic based on physical examination and Ultrasonography

You may not qualify if:

  • Addiction
  • allergic to Opioids and Acetaminophen
  • receiving any types of analgesic drugs within previous 6 hours
  • known cases of Kidney transplantation
  • Patients with known heart failure
  • Patients with known Liver failure
  • Patients with known Respiratory failure
  • Patients with known Renal failure
  • cases of Blindness and physical disabilities not able to communicate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Renal Colic

Interventions

AcetaminophenMorphine

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic Compounds

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Emergency Medicine Specialist

Study Record Dates

First Submitted

July 20, 2013

First Posted

July 24, 2013

Study Start

July 1, 2012

Primary Completion

February 1, 2013

Study Completion

April 1, 2013

Last Updated

July 24, 2013

Record last verified: 2013-07